okebet99 PLEASANTON, Calif. , Dec. 23, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold by Bruker Corporation (Nasdaq: BRKR), which acquired the product line from NanoString Technologies. To minimize the risk of disruption to ongoing research, 10x Genomics requested a carve-out for GeoMx users who installed an instrument prior to the trial in November 2023 . The injunction, which the Court said it will enter in January 2025 , is expected to prohibit Bruker from making, using, selling or offering to sell in the United States its GeoMx Digital Spatial Profiler and associated instruments, reagents and services for RNA and protein detection. At the request of 10x Genomics, the injunction will not block ongoing research by researchers who installed a GeoMx instrument prior to November 18, 2023 . Such customers can continue to purchase GeoMx reagents for use with existing GeoMx instruments for purposes of continuing their ongoing research. The Court found that making such an exception for ongoing research strikes a "workable balance between protecting the patentee's rights and protecting the public from the injunction's adverse effects." In addition, the Court affirmed the $31 million damages awarded by the November 2023 jury verdict, as well as supplemental damages and interest that will be added to the total damages when final judgment is entered. "Today's decision helps to safeguard our decade-long investment in innovation and ensures we can continue to develop groundbreaking technologies that help our customers revolutionize science," said Eric Whitaker , Chief Legal Officer at 10x Genomics. "10x exists to fuel scientific progress – not stifle it – and that is why we've done our utmost to ensure this injunction was structured to protect both our intellectual property and existing GeoMx customers' ongoing research." The Court recognized the harm NanoString's infringing conduct caused 10x when it wrote in its ruling, "Having been careful not to license its technology, 10x suffers when it proclaims itself as an innovator in spatial genomics but a competitor is using the same innovative, patented technology." Today's Court decision follows a November 2023 jury verdict that found that NanoString's GeoMx products willfully infringed seven patents exclusively licensed to 10x Genomics by Prognosys. During the trial, the jury heard testimony from the sole inventor of the patents, Illumina co-founder Mark Chee , and NanoString CEO Brad Gray and NanoString CSO Joe Beechem. After hearing all of the evidence, the jury determined that all seven patents had been infringed by NanoString, that each patent was valid, that NanoString willfully infringed those patents and that monetary damages were owed to 10x for the infringement of all seven patents. In affirming the jury's finding that NanoString willfully infringed, the Court relied on the evidence showing that NanoString knew or was willfully blind that its acts would cause infringement of 10x's rights. The asserted patents in Case No. 21-cv-653-MFK include (a) U.S. Patent No. 10,472,669; (b) U.S. Patent No. 10,961,566; (c) U.S. Patent No. 10,983,113; (d) U.S. Patent No. 10,996,219; (e) U.S. Patent No. 11,001,878; (f) U.S. Patent No. 11,008,607 and (g) U.S. Patent No. 11,293,917. About 10x Genomics 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter) . Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. All statements included in this press release, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "might," "will," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "see," "estimate," "predict," "potential," "would," "likely," "seek" or "continue" or the negatives of these terms or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include statements regarding litigation and remedies as well as possible outcomes of litigation. These forward-looking statements do not reflect that our success will depend on our ability to obtain, maintain and protect our intellectual property rights, intellectual property litigation could be expensive, time-consuming, unsuccessful and could interfere with our ability to develop, manufacture and commercialize our products or technologies, litigation outcomes are unpredictable or there may be changes in our litigation strategy. These statements are based on management's current expectations, forecasts, beliefs, assumptions and information currently available to management. Actual outcomes and results could differ materially from these statements due to a number of factors and such statements should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. The material risks and uncertainties that could affect 10x Genomics, Inc.'s financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's most recently-filed 10-K for the fiscal year ended December 31, 2023 and elsewhere in the documents 10x Genomics, Inc. files with the Securities and Exchange Commission from time to time. Disclosure Information 10x Genomics uses filings with the Securities and Exchange Commission, our website ( www.10xgenomics.com ), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Contacts Investors: investors@10xgenomics.com Media: media@10xgenomics.com View original content to download multimedia: https://www.prnewswire.com/news-releases/us-district-court-awards-10x-genomics-permanent-injunction-in-patent-infringement-lawsuit-against-bruker-corporations-geomx-products-302338627.html SOURCE 10x Genomics, Inc. Best trending stories from the week. Success! An email has been sent to with a link to confirm list signup. Error! There was an error processing your request. You may occasionally receive promotions exclusive discounted subscription offers from the Roswell Daily Record. Feel free to cancel any time via the unsubscribe link in the newsletter you received. You can also control your newsletter options via your user dashboard by signing in.Chitosan Derivatives Market 2024-2031 Explosive Growth, Highly Accurate Outlook, and an Analysis of the Competitive Landscape Comprise the next big thing - FMC Corp, Kitozyme, Kunpoong Bio.

Harris Dickinson toys with ambiguity in ‘Babygirl,’ and keeps a secret from Nicole Kidman Harris Dickinson was nervous to approach Nicole Kidman . Lindsey Bahr, The Associated Press Dec 23, 2024 1:49 PM Share by Email Share on Facebook Share on X Share on LinkedIn Print Share via Text Message Harris Dickinson, left, and Halina Reijn arrive at the premiere of "Babygirl" on Wednesday, Dec. 11, 2024, at the DGA Theater in Los Angeles. (Photo by Richard Shotwell/Invision/AP) Harris Dickinson was nervous to approach Nicole Kidman . This would not necessarily be notable under normal circumstances, but the English actor had already been cast to star opposite her in the erotic drama “Babygirl,” as the intern who initiates an affair with Kidman's buttoned-up CEO. They’d had a zoom with the writer-director Halina Reijn, who was excited by their playful banter and sure that Dickinson would hold his own. And yet when he found himself at the same event as Kidman, shyness took over. He admitted as much to Margaret Qualley, who took things into her own hands and introduced them. “She helped me break the ice a bit,” Dickinson said in a recent interview with The Associated Press. On set would be an entirely different story. Dickinson might not be nearly as “puckishly audacious” as his character Samuel but in the making of “Babygirl,” he, Kidman and Reijn had no choice but to dive fearlessly into this exploration of sexual power dynamics, going to intimate, awkward, exhilarating and meme-able places. It’s made the film, in theaters Christmas Day, one of the year’s must-sees. “There was an unspoken thing that we adhered to,” Dickinson said. “We weren’t getting to know each other’s personal lives. When we were working and we were the characters, we didn’t veer away from the material. I never tried to attach all of the history of Nicole Kidman. Otherwise it probably would have been a bit of a mess.” His is a performance that reconfirms what many in the film world have suspected since his debut seven years ago as a Brooklyn tough questioning his sexuality in Eliza Hittman’s “Beach Rats” : Dickinson is one of the most exciting young talents around. Dickinson, 28, grew up in Leytonstone, in East London — the same neck of the woods as Alfred Hitchcock. Cinema was in his life, whether it was Christopher Nolan’s “Batman” films at the local multiplex or venturing into town to see the more social realist films of Mike Leigh and Ken Loach. “Working class cinema interested me,” he said. “People around me that represented my world.” Appropriately, his entry into making art started behind the camera, with a comedy web series he made as a kid, which he now describes as “really bad spoofs” of films and shows of the time. But things started to really click when he began acting in the local theater. “I remember feeling invigorated by it and accepted,” he said. “I felt myself for the first time and felt able to express myself in a way where I didn’t feel vulnerable and I felt alive and ignited by something.” At around 17, someone suggested that he should give acting a try professionally. He hadn’t even fully understood that it was a career possibility, but he started auditioning. At 20, he was cast in “Beach Rats” and, he said, just “kept going.” Since then, he’s gotten a wide range of opportunities in films both big, including “The King’s Man,” and small. He’s captivated as a male model in Ruben Östlund’s Cannes-winning “Triangle of Sadness,” an estranged father to a 12-year-old in Charlotte Regan’s “Scrapper,” an actor bringing an ex-boyfriend to life in Joanna Hogg’s “The Souvenir Part II,” the charismatic, tragic wrestler David Von Erich in Sean Durkin’s “The Iron Claw” and a soldier in Steve McQueen’s “Blitz.” But “Babygirl” would present new challenges and opportunities with a character who’s almost impossible to define. “He was confusing in a really interesting way. There wasn’t loads of specificity to it, which I enjoyed because it was a bit of a challenge to sort of pinpoint exactly what it was that drove him and made him tick,” Dickinson said. “There was a directness that unlocked a lot for me, like a fearlessness with the way he spoke, or a social unawareness in a way — like not fully realizing what he’s saying is affecting someone in a certain way. But I didn’t make too many rules for him.” Part of the allure of the film is the ever-shifting power dynamics between the two characters, which could change over the course of a scene. As Reijn said, “It’s a cautionary tale about what happens when you suppress your own desires.” She was especially in awe of Dickinson's ability to make everything feel improvised and the fact that he could look like a 12-year-old boy in one shot and a confident 45-year-old man in the next. Since its premiere at the Venice Film Festival earlier this year, the film has led to some surprisingly direct conversations with audiences spanning generations. But that, Dickinson understood, was what Reijn wanted. “She really wanted to show the ugliness and the awkwardness of these things, of these relationships and sex,” he said. “That sort of fumbly version and the performative version of it is way more interesting, to me at least, than the kind of fantasized, romanticized, sexy thing that we’ve seen a lot.” Dickinson recently stepped behind the camera again, directing his first feature film under the banner of his newly formed production company. Set against the backdrop of homelessness in London, “Dream Space” is about a drifter trying to assimilate and understand his cyclical behavior. The film, which wrapped earlier this year, has given him a heightened appreciation for just how many people are indispensable in the making of a film. He’s also started to understand that “acting is just being able to relax.” “When you’re relaxed, you can do stuff that is truthful,” he said. “That only happens if you’ve got good people around you: The director that creates the good environment. The intimacy coordinator facilitating a safe space. A coworker in Nicole encouraging that kind of bravery and performance with what she’s doing.” Dickinson did eventually get to the point where he managed to ask Kidman questions about working with Stanley Kubrick and Lars Von Trier. But he also kept one shattering possibility between himself and his director. “There is a world in which Samuel doesn’t even exist. He’s just a sort of a device or a figment for her own story. And I like that because it kind of means you can take the character into a very unrealistic realm at times and be almost like a deity in the story,” Dickinson said. “We didn’t talk about it with Nicole.” Lindsey Bahr, The Associated Press See a typo/mistake? Have a story/tip? This has been shared 0 times 0 Shares Share by Email Share on Facebook Share on X Share on LinkedIn Print Share via Text Message More Entertainment News Burt, the huge Australian crocodile who had a cameo in ‘Crocodile Dundee,’ dies at 90 Dec 23, 2024 2:00 PM Burt, the huge Australian crocodile who had a cameo in ‘Crocodile Dundee,’ dies at 90 Dec 23, 2024 1:30 PM Movie Review: Nicole Kidman commands the erotic office drama 'Babygirl' Dec 23, 2024 1:14 PM Featured FlyerVictoria’s Secret & Co. ( NYSE:VSCO – Get Free Report ) shot up 5.3% during trading on Friday . The company traded as high as $37.11 and last traded at $36.83. 407,505 shares changed hands during trading, a decline of 85% from the average session volume of 2,709,675 shares. The stock had previously closed at $34.97. Wall Street Analysts Forecast Growth A number of research firms recently weighed in on VSCO. BMO Capital Markets raised their price target on shares of Victoria’s Secret & Co. from $29.00 to $33.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Jefferies Financial Group lifted their target price on Victoria’s Secret & Co. from $30.00 to $40.00 and gave the stock a “buy” rating in a research report on Tuesday, November 12th. The Goldman Sachs Group increased their price target on Victoria’s Secret & Co. from $17.00 to $19.00 and gave the company a “sell” rating in a report on Friday, August 30th. Wells Fargo & Company lifted their price objective on Victoria’s Secret & Co. from $30.00 to $33.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. Finally, Bank of America increased their target price on Victoria’s Secret & Co. from $18.00 to $21.00 and gave the company an “underperform” rating in a research note on Friday, August 30th. Three investment analysts have rated the stock with a sell rating, four have assigned a hold rating and three have given a buy rating to the company. According to data from MarketBeat, Victoria’s Secret & Co. currently has a consensus rating of “Hold” and a consensus target price of $26.30. Get Our Latest Stock Analysis on VSCO Victoria’s Secret & Co. Trading Up 6.1 % Victoria’s Secret & Co. ( NYSE:VSCO – Get Free Report ) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.02. The firm had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.41 billion. Victoria’s Secret & Co. had a return on equity of 44.06% and a net margin of 2.25%. As a group, sell-side analysts forecast that Victoria’s Secret & Co. will post 2.01 EPS for the current year. Institutional Investors Weigh In On Victoria’s Secret & Co. Institutional investors have recently modified their holdings of the business. FMR LLC grew its holdings in shares of Victoria’s Secret & Co. by 146.1% during the third quarter. FMR LLC now owns 2,757,032 shares of the company’s stock valued at $70,856,000 after purchasing an additional 1,636,602 shares during the last quarter. Forest Avenue Capital Management LP bought a new position in Victoria’s Secret & Co. during the 3rd quarter worth $40,861,000. AQR Capital Management LLC increased its position in Victoria’s Secret & Co. by 102.0% in the second quarter. AQR Capital Management LLC now owns 2,708,766 shares of the company’s stock worth $47,864,000 after buying an additional 1,368,103 shares during the period. Bayberry Capital Partners LP bought a new stake in Victoria’s Secret & Co. in the first quarter valued at $11,919,000. Finally, Marshall Wace LLP boosted its holdings in shares of Victoria’s Secret & Co. by 1,218.1% during the second quarter. Marshall Wace LLP now owns 618,195 shares of the company’s stock valued at $10,924,000 after acquiring an additional 571,295 shares during the period. Institutional investors own 90.29% of the company’s stock. About Victoria’s Secret & Co. ( Get Free Report ) Victoria's Secret & Co operates as a specialty retailer of women's intimate, and other apparel and beauty products worldwide. It offers bras, panties, lingerie, casual sleepwear, and athleisure and swim, as well as fragrances and body care; and loungewear, knit tops, activewear, and accessories and beauty under the Victoria's Secret, PINK, and Adore Me brands. Recommended Stories Receive News & Ratings for Victoria's Secret & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victoria's Secret & Co. and related companies with MarketBeat.com's FREE daily email newsletter .CleanSpark, Inc. ( NASDAQ:CLSK – Get Free Report ) CTO Taylor Monnig sold 1,350 shares of CleanSpark stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $10.40, for a total value of $14,040.00. Following the sale, the chief technology officer now directly owns 201,520 shares in the company, valued at $2,095,808. The trade was a 0.67 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website . Taylor Monnig also recently made the following trade(s): CleanSpark Trading Down 5.6 % Shares of CleanSpark stock opened at $9.78 on Friday. The stock has a market capitalization of $2.86 billion, a price-to-earnings ratio of -16.86 and a beta of 4.16. The firm’s 50-day moving average price is $12.90 and its two-hundred day moving average price is $13.00. CleanSpark, Inc. has a 1-year low of $6.41 and a 1-year high of $24.72. Wall Street Analysts Forecast Growth Read Our Latest Analysis on CleanSpark Institutional Investors Weigh In On CleanSpark Large investors have recently bought and sold shares of the business. Marshall Wace LLP bought a new position in CleanSpark in the 2nd quarter valued at $18,074,000. Van ECK Associates Corp increased its stake in shares of CleanSpark by 64.0% in the third quarter. Van ECK Associates Corp now owns 1,590,688 shares of the company’s stock valued at $14,857,000 after buying an additional 620,792 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of CleanSpark by 9.8% in the third quarter. Geode Capital Management LLC now owns 6,163,461 shares of the company’s stock valued at $57,577,000 after buying an additional 549,187 shares during the last quarter. Millennium Management LLC grew its holdings in CleanSpark by 74.6% during the 2nd quarter. Millennium Management LLC now owns 1,251,278 shares of the company’s stock worth $19,958,000 after acquiring an additional 534,825 shares during the last quarter. Finally, Barclays PLC raised its stake in shares of CleanSpark by 364.0% in the third quarter. Barclays PLC now owns 389,201 shares of the company’s stock worth $3,634,000 after acquiring an additional 305,316 shares during the last quarter. 43.12% of the stock is currently owned by institutional investors. CleanSpark Company Profile ( Get Free Report ) CleanSpark, Inc operates as a bitcoin miner in the Americas. It owns and operates data centers that primarily run on low-carbon power. Its infrastructure supports Bitcoin, a digital commodity and a tool for financial independence and inclusion. The company was formerly known as Stratean Inc and changed its name to CleanSpark, Inc in November 2016. Read More Receive News & Ratings for CleanSpark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CleanSpark and related companies with MarketBeat.com's FREE daily email newsletter .

First Interstate BancSystem, Inc. ( NASDAQ:FIBK – Get Free Report ) shares hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $34.56 and last traded at $34.36, with a volume of 71552 shares traded. The stock had previously closed at $33.83. Wall Street Analysts Forecast Growth Several research analysts have recently commented on FIBK shares. Wells Fargo & Company lowered shares of First Interstate BancSystem from an “equal weight” rating to an “underweight” rating and lowered their price objective for the company from $30.00 to $28.00 in a research note on Tuesday, October 1st. Barclays downgraded shares of First Interstate BancSystem from an “equal weight” rating to an “underweight” rating and dropped their price target for the stock from $32.00 to $30.00 in a research note on Thursday, October 31st. Piper Sandler reduced their price objective on First Interstate BancSystem from $38.00 to $36.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. StockNews.com cut First Interstate BancSystem from a “hold” rating to a “sell” rating in a research note on Wednesday. Finally, Stephens reaffirmed an “overweight” rating and issued a $36.00 price target on shares of First Interstate BancSystem in a research report on Thursday, October 10th. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $32.50. Check Out Our Latest Analysis on First Interstate BancSystem First Interstate BancSystem Stock Up 1.7 % First Interstate BancSystem ( NASDAQ:FIBK – Get Free Report ) last released its quarterly earnings data on Thursday, October 24th. The financial services provider reported $0.54 EPS for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.04). First Interstate BancSystem had a net margin of 15.94% and a return on equity of 7.48%. During the same period in the previous year, the company posted $0.70 earnings per share. On average, equities research analysts anticipate that First Interstate BancSystem, Inc. will post 2.28 EPS for the current fiscal year. First Interstate BancSystem Announces Dividend The business also recently declared a quarterly dividend, which was paid on Thursday, November 14th. Shareholders of record on Monday, November 4th were paid a $0.47 dividend. The ex-dividend date of this dividend was Monday, November 4th. This represents a $1.88 annualized dividend and a yield of 5.47%. First Interstate BancSystem’s dividend payout ratio is currently 82.46%. Insider Transactions at First Interstate BancSystem In other news, Director Jonathan R. Scott sold 6,500 shares of First Interstate BancSystem stock in a transaction dated Wednesday, November 13th. The stock was sold at an average price of $34.18, for a total transaction of $222,170.00. Following the sale, the director now owns 958,710 shares in the company, valued at approximately $32,768,707.80. The trade was a 0.67 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link . Also, major shareholder Julie A. Scott sold 20,220 shares of the company’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $32.78, for a total value of $662,811.60. Following the completion of the sale, the insider now directly owns 635,069 shares of the company’s stock, valued at approximately $20,817,561.82. This trade represents a 3.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here . In the last quarter, insiders sold 48,770 shares of company stock worth $1,630,272. 6.90% of the stock is currently owned by insiders. Hedge Funds Weigh In On First Interstate BancSystem A number of hedge funds have recently modified their holdings of FIBK. Point72 DIFC Ltd acquired a new stake in First Interstate BancSystem during the 3rd quarter worth $34,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of First Interstate BancSystem during the third quarter worth about $69,000. CWM LLC grew its holdings in shares of First Interstate BancSystem by 16.0% during the second quarter. CWM LLC now owns 3,123 shares of the financial services provider’s stock worth $87,000 after buying an additional 430 shares during the last quarter. Innealta Capital LLC acquired a new position in First Interstate BancSystem in the 2nd quarter valued at about $106,000. Finally, nVerses Capital LLC raised its stake in First Interstate BancSystem by 412.5% during the 2nd quarter. nVerses Capital LLC now owns 4,100 shares of the financial services provider’s stock valued at $114,000 after acquiring an additional 3,300 shares during the last quarter. 88.71% of the stock is currently owned by hedge funds and other institutional investors. About First Interstate BancSystem ( Get Free Report ) First Interstate BancSystem, Inc operates as the bank holding company for First Interstate Bank that provides range of banking products and services in the United States. It offers various traditional depository products, including checking, savings, and time deposits; and repurchase agreements primarily for commercial and municipal depositors. Featured Stories Receive News & Ratings for First Interstate BancSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Interstate BancSystem and related companies with MarketBeat.com's FREE daily email newsletter .MOSCOW (AP) — Russian police raided several bars and nightclubs across Moscow on Saturday as part of the government’s crackdown on “LGBTQ+ propaganda,” state media reported. Read this article for free: Already have an account? To continue reading, please subscribe: * MOSCOW (AP) — Russian police raided several bars and nightclubs across Moscow on Saturday as part of the government’s crackdown on “LGBTQ+ propaganda,” state media reported. Read unlimited articles for free today: Already have an account? MOSCOW (AP) — Russian police raided several bars and nightclubs across Moscow on Saturday as part of the government’s crackdown on “LGBTQ+ propaganda,” state media reported. Smartphones, laptops and video cameras were seized, while clubgoers had their documents inspected by officers, Russia’s Tass news agency said, citing sources in law enforcement. The raids come exactly a year since Russia’s Supreme Court ruled that the “LGBTQ+ movement” should be banned as an “extremist organization.” Its decision followed a decades-long crackdown on LGBTQ+ rights in Russia, where President Vladimir Putin has touted “traditional family values” as a cornerstone of his quarter-century in power. Footage shared on social media appeared to show partygoers being ordered by police to lie on the floor as officers moved through Moscow’s Arma nightclub. The capital’s Mono bar was also targeted, Russian media reported. In a post on Telegram on Saturday, the club’s management didn’t directly reference an incident with law enforcement, but wrote, “Friends, we’re so sorry that what happened, happened. They didn’t find anything forbidden. We live in such times, but life must go on.” Police also detained the head of the “Men Travel” tour agency on Saturday under anti-LGBT laws, Tass reported. The news agency said that the 48-year-old was suspected of preparing a trip for “the supporters of nontraditional sexual values” to visit Egypt over Russia’s New Year’s holidays. The raids mirror the concerns of Russian activists who warned that Moscow’s designation of the “LGBTQ+ movement” as “extremist” — despite it not being an official entity — could see Russian authorities crack down at will on groups or individuals. Other recent laws have also served to put pressure on those that the Russian government believes aren’t in line with the country’s “traditional values.” On Nov. 23, Putin signed into law a bill banning the adoption of Russian children by citizens of countries where gender-affirming care is legal. The Kremlin leader also approved legislation that outlaws the spread of material that encourages people not to have children. Advertisement

Brian de Peña: from employee at Dominican hotel to Mayor of Lawrence, USAOil company Phillips 66 faces federal charges related to alleged Clean Water Act violations LOS ANGELES (AP) — Oil company Phillips 66 has been federally indicted in connection with alleged violations of the Clean Water Act in California. The Texas-based company is accused of discharging hundreds of thousands of gallons of industrial wastewater containing excessive amounts of oil and grease. The U.S. Department of Justice announced the indictment on Thursday. Phillips is charged with two counts of negligently violating the Clean Water Act and four counts of knowingly violating the Clean Water Act. An arraignment date has not been set. A spokesperson for the company said it was cooperating with prosecutors. US regulators seek to break up Google, forcing Chrome sale as part of monopoly punishment U.S. regulators want a federal judge to break up Google to prevent the company from continuing to squash competition through its dominant search engine after a court found it had maintained an abusive monopoly over the past decade. The proposed breakup floated in a 23-page document filed late Wednesday by the U.S. Justice Department calls for Google to sell its industry-leading Chrome web browser and impose restrictions designed to prevent Android from favoring its search engine. Regulators also want to ban Google from forging multibillion-dollar deals to lock in its dominant search engine as the default option on Apple’s iPhone and other devices. What you need to know about the proposed measures designed to curb Google's search monopoly U.S. regulators are proposing aggressive measures to restore competition to the online search market after a federal judge ruled that Google maintained an illegal monopoly. The sweeping set of recommendations filed late Wednesday could radically alter Google’s business. Regulators want Google to sell off its industry-leading Chrome web browser. They outlined a range of behavioral measures such as prohibiting Google from using search results to favor its own services such as YouTube, and forcing it to license search index data to its rivals. They're not going as far as to demand Google spin off Android, but are leaving that door open if the remedies don't work. SEC Chair Gary Gensler, who led US crackdown on cryptocurrencies, to step down Securities and Exchange Commission Chair Gary Gensler will step down from his post on January 20. Since taking the lead at the SEC, the commission has been aggressive in its oversight of cryptocurrencies and other regulatory issues. President-elect Donald Trump had promised during his campaign that he would remove Gensler, who has led the U.S. government’s crackdown on the crypto industry and repeatedly called for more oversight. But Gensler on Thursday announced that he would be stepping down from his post on the day that Trump is inaugurated. Bitcoin has jumped 40% since Trump’s victory. US intelligence warns defense companies of Russian sabotage threat WASHINGTON (AP) — U.S. intelligence officials are warning American defense companies to increase their security after a wave of sabotage in Europe blamed on Russia. The National Counterintelligence and Security Center issued a public bulletin Thursday advising companies that work in the defense industry that Russia may seek to carry out acts of sabotage as part of its effort to undercut Ukraine's allies and their ability to support Ukraine in its defense against Russia. Western authorities say they believe Russian intelligence is behind several recent acts of sabotage targeting European defense companies. Russia has denied the allegations. Elon Musk's budget crusade could cause a constitutional clash in Trump's second term WASHINGTON (AP) — Donald Trump has put Elon Musk and Vivek Ramaswamy in charge of finding ways to cut government spending and regulations. It's possible that their efforts will lead to a constitutional clash. This week, Musk and Ramaswamy said they would encourage the Republican president-elect to refuse to spend money allocated by Congress, which would conflict with a 1974 law that's intended to prevent presidents from blocking funds. If Trump takes such a step, it would quickly become one of the most closely watched legal battles of his second administration. Musk and Ramaswamy also aim to dramatically reduce the size of the federal workforce. Bitcoin is at the doorstep of $100,000 as post-election rally rolls on NEW YORK (AP) — Bitcoin is jumping again, rising above $98,000 for the first time Thursday. The cryptocurrency has been shattering records almost daily since the U.S. presidential election, and has rocketed more than 40% higher in just two weeks. It's now at the doorstep of $100,000. Cryptocurrencies and related investments like crypto exchange-traded funds have rallied because the incoming Trump administration is expected to be more “crypto-friendly.” Still, as with everything in the volatile cryptoverse, the future is hard to predict. And while some are bullish, other experts continue to warn of investment risks. Cutting in line? American Airlines' new boarding tech might stop you at now over 100 airports NEW YORK (AP) — Sneaking a little ahead of line to get on that plane faster? American Airlines might stop you. In an apparent effort to reduce the headaches caused airport line cutting, American has rolled out boarding technology that alerts gate agents with an audible sound if a passenger tries to scan a ticket ahead of their assigned group. This new software won’t accept a boarding pass before the group it’s assigned to is called, so customers who get to the gate prematurely will be asked to go back and wait their turn. As of Wednesday, the airline announced, this technology is now being used in more than 100 U.S. airports that American flies out of. The official expansion arrives after successful tests in three of these locations. Stock market today: Wall Street rises with Nvidia as bitcoin bursts above $99,000 NEW YORK (AP) — U.S. stocks climbed after market superstar Nvidia and another round of companies said they’re making even fatter profits than expected. The S&P 500 pulled 0.5% higher Thursday after flipping between modest gains and losses several times in the morning. The Dow Jones Industrial Average jumped 1.1%, and the Nasdaq composite edged up by less than 0.1%. Banks, smaller companies and other areas of the stock market that tend to do best when the economy is strong helped lead the way, while bitcoin briefly broke above $99,000. Crude oil, meanwhile, continued to rise. Treasury yields inched higher in the bond market. What will happen to CNBC and MSNBC when they no longer have a corporate connection to NBC News? Two television networks with “NBC” in their names — MSNBC and CNBC — will no longer have any corporate connection to NBC News once a spinoff formally takes effect in about a year. Comcast is cutting loose several of its cable companies into a separate company in order to improve its bottom line. It leaves several questions, particularly for MSNBC. Will the news network geared to liberal viewers continue to use NBC News personnel? Will it have to leave its offices and studios at the NBC News headquarters in New York's Rockefeller Center? Will they even keep the same names?

CHARLESTOWN, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that it was added to the Nasdaq Biotechnology Index ® (Nasdaq: NBI) effective prior to the market open on Monday, December 23, 2024. The Nasdaq Biotechnology Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market ® (Nasdaq ® ) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). The NBI is calculated under a modified capitalization-weighted methodology. Companies in the NBI must meet eligibility requirements, including minimum market capitalization, average daily trading volume, and seasoning as a public company, among other criteria. Nasdaq selects constituents once annually in December. For more information about the Nasdaq Biotechnology Index, please visit https://indexes.nasdaqomx.com/Index/Overview/NBI . About Solid Biosciences Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates including SGT-003 for the treatment of Duchenne muscular dystrophy (Duchenne), SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia (CPVT), SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, SGT-401 for the treatment of BAG3-mediated dilated cardiomyopathy, and additional assets for the treatment of fatal cardiac diseases. Solid is advancing its diverse pipeline across rare neuromuscular and cardiac diseases, bringing together experts in science, technology, disease management, and care. Patient-focused and founded by those directly impacted, Solid’s mandate is to improve the daily lives of patients living with these devastating diseases. For more information, please visit www.solidbio.com . Solid Biosciences Investor Contact: Nicole Anderson Director, Investor Relations and Corporate Communications Solid Biosciences Inc. investors@solidbio.com Media Contact: Glenn Silver FINN Partners glenn.silver@finnpartners.com